Indicated for: breast cancer
Route of administration: oral
Substance: exemestane (aromatase inhibitor)
ATC: L02BG06 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors)
Exemestane is a medication used in the treatment of hormone-dependent breast cancer in postmenopausal women. It belongs to the class of aromatase inhibitors and works by reducing estrogen levels in the body, which slows or stops the growth of tumors that require estrogen to grow.
It is indicated for the treatment of early-stage breast cancer after tamoxifen therapy or for advanced or metastatic breast cancer. Exemestane is taken orally in tablet form, usually once daily after a meal.
Side effects may include hot flashes, fatigue, joint or muscle pain, insomnia, nausea, osteoporosis or decreased bone density, and excessive sweating. Rarely, allergic reactions or liver disorders may occur.
Exemestane is contraindicated in premenopausal women, during pregnancy, or while breastfeeding. It is important to take the medication as prescribed by a doctor, and patients should be monitored regularly to assess effectiveness and potential side effects.